$ AAPL

$ ABBV

$ ABNB

$ ACGL

$ ADI

$ ADM

$ ADP

$ ADSK

$ AEE

$ AEP

$ AES

$ AFL

$ AIG

$ AIZ

$ AJG

$ AKAM

$ ALB

$ ALGN

$ ALL

$ AMAT

$ AMCR

$ AMD

$ AME

$ AMGN

$ AMP

$ AMT

$ AMZN

$ ANET

$ AOS

$ APA

$ APD

$ APO

$ APTV

$ ARE

$ ATO

$ AVB

$ AWK

$ AXON

$ BA

$ BALL

$ BAX

$ BBY

$ BDX

$ BEN

$ BG

$ BIIB

$ BKNG

$ BLDR

$ BMY

$ BR

$ BRO

$ BXP

$ CAG

$ CAH

$ CARR

$ CAT

$ CBOE

$ CBRE

$ CCL

$ CDNS

$ CDW

$ CEG

$ CF

$ CHD

$ CHRW

$ CI

$ CINF

$ CL

$ CLX

$ CMCSA

$ CMG

$ CMI

$ CMS

$ COIN

$ COO

$ COP

$ COR

$ CPAY

$ CPT

$ CRL

$ CRWD

$ CSCO

$ CTRA

$ CTSH

$ CTVA

$ CVS

$ CVX

$ CZR

$ DAL

$ DASH

$ DAY

$ DD

$ DDOG

$ DE

$ DELL

$ DG

$ DGX

$ DIS

$ DOC

Bunge Global SA’s Q2 2025 EPS beat was overshadowed by margin compression, rising debt, and a looming share resale, with investors awaiting clearer benefits from the Viterra integration.

# Bunge Global SA Q2 2025: EPS Beat Masks Margin Pressures and Debt Concerns Amid Strategic Transition

---

## Executive Summary

- **Bunge Global SA delivered an adjusted EPS of $1.31 in Q2 2025, beating consensus by $0.15**, but this was down from $1.73 a year ago, highlighting underlying margin and profitability headwinds despite the headline beat.
- **Revenue declined 3.6% YoY to $12.769B**, with no clear volume or pricing drivers, and one-off items influencing the bottom line. Gross profit improved, but **net margin compressed to 1.73%** and adjusted EBIT fell sharply, reflecting ongoing challenges in Refined & Specialty Oils and Milling.
- **Management struck a balanced tone**, emphasizing cost control and South American processing strength, but maintained a cautious outlook by holding full-year adjusted EPS guidance at $7.75, signaling conservative expectations for the remainder of 2025.
- **Key risks include increased leverage, a looming 65.6M share resale, and persistent margin pressures**, particularly in U.S. biofuels. However, the Viterra integration and above-peer net margin/ROE offer potential upside if execution improves.
- **Catalyst watch:** Progress on Viterra integration, updates on the secondary share offering, and clarity on U.S. biofuel policy will be critical for the stock’s near-term direction.

---

## Performance Snapshot

| Metric                | Reported   | Consensus | Surprise | YoY Change      |
|-----------------------|------------|-----------|----------|-----------------|
| Revenue               | $12.769B   | —         | —        | -3.6%           |
| Adjusted EPS          | $1.31      | $1.16     | +$0.15   | -24%            |
| Net Margin            | 1.73%      | —         | —        | -0.3pp          |
| Adjusted EBIT         | $293M      | —         | —        | -28%            |
| Gross Profit          | $738M      | —         | —        | +11%            |
| SG&A Expense          | $418M      | —         | —        | -7%             |

*Note: Additional KPIs such as segment margins and debt levels are material to the quarter’s context.*

---

## Earnings Quality

- **Revenue mix was pressured by declines in Refined & Specialty Oils and Milling**, with South American processing providing a partial offset. The gross profit increase was not enough to prevent **net margin compression**, as adjusted EBIT fell from $405M to $293M.
- **SG&A expense improvement** (down $31M YoY) reflects effective cost control, but **rising debt levels and interest expense** are emerging as material headwinds.
- The divergence between gross profit growth and declining EBIT/net margin underscores the impact of **segment-specific margin pressures and higher non-operating costs**.

---

## Management Commentary & Guidance

- **Management’s tone was balanced but cautious**, highlighting operational wins in South America and cost discipline, while openly acknowledging margin challenges in key segments.
- **Guidance for full-year adjusted EPS was maintained at $7.75**, despite the Q2 beat, reflecting a conservative stance and limited visibility on the pace of Viterra integration synergies and external market recovery.
- No quantitative update was provided on Viterra synergy targets, and the company is focused on completing the corn milling divestiture.

---

## Key Risks

- **Leverage risk:** Both short- and long-term debt increased, raising concerns about interest expense and balance sheet flexibility.
- **Share overhang:** The planned resale of 65.6M shares could pressure the stock and dilute existing holders.
- **Margin headwinds:** Ongoing challenges in Refined & Specialty Oils and Milling, exacerbated by U.S. biofuel policy uncertainty.
- **Revenue growth lag:** Bunge Global SA continues to trail peers on top-line growth, which could limit valuation upside.

---

## Expected Market Reaction

- **Analysts and investors are likely to react cautiously**: The EPS beat is offset by revenue declines, margin compression, and the overhang from the secondary share offering.
- **Operational improvements in South America and cost controls are positives**, but the market may remain skeptical until Viterra integration benefits and margin recovery become more visible.

---

## Final Takeaway

- **Q2 2025 was a mixed quarter for Bunge Global SA**: While the company delivered a headline EPS beat and demonstrated cost discipline, underlying margin pressures, increased leverage, and a significant share overhang signal a fragile earnings quality.
- **The market may be underappreciating Bunge’s above-peer net margin and ROE**, but is likely not fully pricing in the risks from margin headwinds and higher debt.
- **Upcoming catalysts:** Progress updates on Viterra integration and the timing/impact of the 65.6M share resale, as well as any regulatory developments in U.S. biofuels, will be key to the stock’s near-term trajectory.

Bunge (BG) Q2: Margin, Debt, and Integration Risks

Bunge Global faces ongoing margin compression, regulatory uncertainty, and working capital pressures, leading to a cautious near-term outlook despite reaffirmed full-year EPS guidance.

# Bunge Global: Navigating Margin Pressures and Regulatory Uncertainty Ahead of Q2 Earnings

## Executive Summary

We maintain a **Neutral** outlook on Bunge Global (BG) for the upcoming quarter, as persistent margin compression and regulatory headwinds are likely to offset isolated segmental strengths. **Q1 2025 revenue of $11.6 billion** marked a **13% YoY decline**, with gross margin at **5.1%** and operating margin at **2.8%**, both under pressure from cost inflation and softening demand. Management’s reaffirmed full-year EPS guidance of **$7.75** is encouraging, but their explicit warning of a “softer” Q2 signals near-term caution. The market may be underestimating the impact of a **$315 million QoQ working capital build**, which could constrain operational flexibility and free cash flow in the next quarter.

## Recent Trends Signal What’s Next

Bunge’s last two quarters have been characterized by declining revenues and tightening margins, setting a challenging baseline for Q2. **Q1 2025 revenue fell 13% YoY** to $11.6 billion, with gross margin compressing to **5.1%** and operating margin to **2.8%**. Net income and EPS have followed suit, reflecting both top-line and cost-side pressures. Segment data shows **Agribusiness net sales down 16% YoY** (volumes -9.5%) and **Refined & Specialty Oils EBIT down 49% YoY**. The following table summarizes the last four quarters’ key financials:

### Quarterly Financial Trends

| Quarter    | Revenue ($B) | Gross Margin (%) | Operating Margin (%) | EPS ($) |
|------------|--------------|------------------|----------------------|---------|
| Q2 2024    | 13.2         | 6.4              | 3.7                  | 2.15    |
| Q3 2024    | 12.8         | 6.0              | 3.3                  | 1.98    |
| Q4 2024    | 12.1         | 5.6              | 3.0                  | 1.62    |
| Q1 2025    | 11.6         | 5.1              | 2.8                  | 1.41    |

**Trend:** Revenue and margins have declined sequentially, with EPS following the same trajectory, indicating persistent headwinds likely to continue into Q2.

## Management’s Forward Tone and Positioning

Management’s recent commentary has shifted from confidence to caution. In the Q1 2025 call, they stated:  
> “We expect Q2 to be softer, reflecting some pull-forward from Q1 and ongoing margin pressures.”  
This contrasts with prior quarters’ language, which emphasized “resilience” and “strong execution.” The current tone acknowledges “uncertainty” and a “dynamic” market environment, signaling a more defensive posture. The reaffirmation of full-year EPS guidance is notable, but the near-term messaging is clearly more guarded, with explicit references to regulatory and integration risks.

## KPI Trends & Upcoming Quarter Drivers

Key performance indicators point to continued operational challenges:

- **Agribusiness Volumes:** Down to **18.3 million metric tons** (-9.5% YoY), signaling weaker demand and lower throughput.
- **Inventory Levels:** Up to **$7.817 billion**, reflecting a **$315 million QoQ increase**—likely tied to the South American harvest and slower inventory turnover.
- **Capex:** Elevated at **$310 million in Q1** (+31% YoY), contributing to **negative free cash flow of -$595 million**.

### KPI Movement Table

| KPI                    | Q1 2024 | Q4 2024 | Q1 2025 | YoY Change | QoQ Change |
|------------------------|---------|---------|---------|------------|------------|
| Agribusiness Volumes (MMT) | 20.2    | 19.1    | 18.3    | -9.5%      | -4.2%      |
| Inventory ($B)         | 6.9     | 7.5     | 7.8     | +13%       | +4%        |
| Capex ($M)             | 237     | 265     | 310     | +31%       | +17%       |

**Implication:** Lower volumes and higher inventories will likely pressure revenue and working capital, while elevated capex could weigh on near-term EPS and liquidity.

## Missed by the Street

Two subtle but material signals are being overlooked:

1. **Working Capital Build:** The **$315 million QoQ increase in working capital**—largely from inventory tied to the South American harvest—could limit Bunge’s ability to respond to market shifts and may pressure free cash flow in Q2.
2. **Portfolio Optimization Efforts:** Management’s repeated references to “portfolio optimization” and “risk management” suggest behind-the-scenes cost and asset discipline, which could mitigate downside but are not yet visible in headline numbers.

## Scenarios for the Upcoming Quarter

### Scenario Table

| Scenario | Revenue ($B) | EPS ($) | Operating Margin (%) | Key Assumptions                                              |
|----------|--------------|---------|----------------------|--------------------------------------------------------------|
| Bull     | 11.8–11.9    | 1.45–1.55| 2.8–3.0              | Commodity prices stabilize, regulatory clarity, cost control |
| Base     | 11.5–11.7    | 1.30–1.45| 2.6–2.8              | Persistent cost pressures, regulatory delays                 |
| Bear     | 11.2–11.4    | 1.10–1.25| 2.3–2.5              | FX headwinds, delayed integration, adverse weather           |

**Most Likely:** The **Base case** is most probable, given ongoing cost and regulatory pressures, with limited evidence of a near-term demand rebound or margin recovery.

## Appendix – Data Tables & Management Quotes

### Quarterly Financials Table

| Quarter    | Revenue ($B) | EPS ($) | Gross Margin (%) | Operating Margin (%) |
|------------|--------------|---------|------------------|----------------------|
| Q2 2024    | 13.2         | 2.15    | 6.4              | 3.7                  |
| Q3 2024    | 12.8         | 1.98    | 6.0              | 3.3                  |
| Q4 2024    | 12.1         | 1.62    | 5.6              | 3.0                  |
| Q1 2025    | 11.6         | 1.41    | 5.1              | 2.8                  |

### KPI Movement Table

| KPI                    | Q1 2024 | Q4 2024 | Q1 2025 | YoY Change | QoQ Change |
|------------------------|---------|---------|---------|------------|------------|
| Agribusiness Volumes (MMT) | 20.2    | 19.1    | 18.3    | -9.5%      | -4.2%      |
| Inventory ($B)         | 6.9     | 7.5     | 7.8     | +13%       | +4%        |
| Capex ($M)             | 237     | 265     | 310     | +31%       | +17%       |

### Key Management Quotes

1. **“We expect Q2 to be softer, reflecting some pull-forward from Q1 and ongoing margin pressures.”**  
   *Q1 2025 Earnings Call*  
   *Signals near-term earnings headwinds and a cautious outlook.*

2. **“We continue to see uncertainty in the external environment, particularly around regulatory outcomes.”**  
   *Q1 2025 Earnings Call*  
   *Highlights risk from regulatory reviews, especially Viterra integration.*

3. **“Our focus remains on portfolio optimization and disciplined risk management.”**  
   *Q1 2025 Earnings Call*  
   *Suggests ongoing cost and asset discipline, which could limit downside.*

4. **“Working capital increased by $315 million, primarily due to inventory build in South America.”**  
   *Q1 2025 10-Q*  
   *Points to potential liquidity and operational flexibility constraints.*

5. **“We reaffirm our full-year adjusted EPS guidance of approximately $7.75.”**  
   *Q1 2025 Earnings Call*  
   *Indicates management’s confidence in longer-term recovery, despite near-term softness.*

6. **“Capex increased 31% YoY as we invest in strategic growth initiatives.”**  
   *Q1 2025 10-Q*  
   *Elevated capex may pressure near-term free cash flow and EPS.*

7. **“We are monitoring commodity and FX volatility closely as these remain key risks.”**  
   *Q1 2025 Earnings Call*  
   *Acknowledges ongoing external risks that could impact Q2 results.*

---

**Bottom Line:**  
Bunge’s Q2 is likely to remain challenged by margin compression, regulatory uncertainty, and working capital constraints. While management’s longer-term confidence is notable, near-term results will hinge on cost control and the pace of regulatory clarity. The base case scenario—flat to slightly lower revenue and EPS—remains the most probable outcome for the upcoming quarter.

Bunge (BG): Margin Pressures and Regulatory Risks Persist